Alendronate/Calcitriol

阿仑膦酸/骨化三醇

Report date: 2022/01/14 13:23:58

Base Information

Drug NameAlendronate/Calcitriol
Drug Alias NameAlendronate+Calcitriol骨化三醇+阿仑膦酸Calcitriol+Alendronate骨化三醇/阿仑膦酸Calcitriol/Alendronate +[8
ClassificationSmall molecules
Mechanisms of ActionOsteoclasts inhibitorsVitamin D receptor antagonists
TargetsVitamin D receptor
Therapy Area/IndicationsOsteoporosis
Global Approved IndicationsOsteoporosis
Approved Indications in ChinaN/A
Original Approved Country/TerritorySouth Korea
Original Approved Date2004/10/01
Country/TerritorySouth Korea
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesYuyu Pharma
China Registration ClassN/A

Develop Information

Active CompaniesYuyu Pharma
Inactive CompaniesYuyu Pharma. Inc
Active IndicationsOsteoporosis
Inactive IndicationsN/A

Other Information

ATC CodeM05BB
Related LinksN/A